Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy

Diabetic Medicine

Volumn 15, Issue 6, 1998, Pages 458-462

  Yamaguchi, M ^a   Nakamura, N ^b   Nakano, K ^a   Kitagawa, Y ^b   Shigeta, H ^c   Hasegawa, G ^b   Lenaga, K ^a   Nakamura, K ^b   Nakazawa, Y ^a   Fukui, I ^a   Obayashi, H ^c   Kondo, M ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Nippon Zoki Pharmaceutical Co   (Japan)

^c Kyoto Microbiological Institute   (Japan)

Author keywords

Advanced glycation endproducts; Crossline; Diabetic complication; Diabetic retinopathy; Erythrocyte membrane

Indexed keywords

ERYTHROCYTE BAND 4.1 PROTEIN; GLYCOSYLATED PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROTEIN CROSS LINKING; PROTEIN DETERMINATION; PROTEIN GLYCOSYLATION;

AGED; BLOOD PROTEINS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE MEMBRANE; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MAILLARD REACTION; MALE; MEMBRANE PROTEINS; MIDDLE AGED;

EID: 7144227270     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199806)15:6<458::AID-DIA601>3.0.CO;2-Q     Document Type: Article

References (22)

1. Monnier VM, Cerami A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 1981; 211:491-493.
2. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984; 101: 527-537.
3. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994; 70: 138-151.
4. Ahmed MU, Thorpe SR, Baynes JW. Identification of N-e-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986; 261: 4889-4894.
5. Njoroge FC, Sayre LM, Monnier VM. Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohydr Res 1987; 167:211-220.
6. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. Impli-cation of pentosee in the aging process. J Biol Chem 1989; 264: 21597-21602.
7. Nakamura K, Hasegawa T, Fukunaga Y, lenaga K. Crossline A and B as candidates for the fluorophores in age- and diabetes-related crosslinked protein and their diabetes produced by Maillard reaction of a-N-acetyl-L-lysine with d-glucose. J Chem Soc Chem Commun 1992; 14:992-994.
8. lenaga K, Kakita H, Hochi T, Nakamura K, Nakazawa Y, Fukunaga Y, ef, aJ. Crossline-structure accumulates as fluorescent advanced glycation endproducts in renal tissue of rats with diabetic nephropathy. Proc Japan Acad 1996; 72B: 79-84.
9. Obayashi H, Nakano K, Shigeta H, Yamaguchi M, Yoshimori K, Fukui M, et al. Formation of crossline as fluorescent advanced glycation end product in vitro and in vivo. Biochem Biophys Res Commun 1996; 226: 37-41.
10. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
11. Tovvbin H, Staehelin T, Cordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets; procedure and some applications. Proc Natl Acad Sc/1979; 76:4350-4354.
12. TanedaS, MonnierVM. ELISAofpentosidine, an advanced glycation end product, in biological specimens. Clin Chem 1994; 40: 1766-1773.
13. Schleicher E, Scheller L, Wieland OH. Quantitäten of lysine-bound glucose of normal and diabetic erythrocyte membranes by HPLC analysis of furosin [e-N(Lfuroylmethyl)-L-lysine]. Biochem Biophys Res Commun 1981; 99: 1011-1019.
14. Bryszewska M, Szosland K. Association between the glycation of erythrocyte membrane proteins and membrane fluidity. Clin Biochem 1988; 21: 49-51.
15. Watala C, Zawodniak M, Bryszewska M, Nowak S. Nonenzymatic protein glycosylation. I. Lowered erythrocyte membrane fluidity in juvenile diabetes. Ann Clin Res 1985; 17: 327-330.
16. Miller JA, Gravallese E, Bunn HF. Nonenzymatic glycosylation of erythrocyte membrane proteins. Relevance to diabetes. J Clin Invest 1980; 65: 896-901.
17. Monnier VM, Vishwanath V, Frank KE, Elmets ÇA, Dauchot PJ, Kohn RR. Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986; 314: 403-408.
18. McCance DR, Dyer DG, Dünn JA, Bailie KE, Thorpe SR, Baynes JW, et al. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 1993; 91: 2470-2478.
19. Bunn HF, Haney DN, Kamin S, Gabbay KH, Gallop PM. The biosynthesis of human hemoglobin A,c: slow glycosylation of hemoglobin in vivo. J Clin Invest 1976; 57:1652-1659.
20. Makita Z, Vlassara H, Rayfield E, Cartwright K, Friedman E, Rodby R, Cerami A, Bucala R. Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science 1992; 258: 651-653.
21. Vlassara H, Valinsky J, Brownlee M, Cerami C, Nishimoto S, Cerami A. Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. J Exp Med 1987; 166: 539-549.
22. Wautier JL, Wautier MP, Schmidt AM, Anderson CM, Hori O, Zoukourian C, ef al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surfaceassociated AGEs and diabetic complications. Proc Natl Acad Sei 1994; 91: 7742-7746.